June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

ChemChina, Syngenta to move quickly on U.S. national security review

Published 04/02/2016, 08:26
© Reuters. Logo of Syngenta on it's headquarters in Basel
PHG
-
SYENF
-

By Diane Bartz

WASHINGTON (Reuters) - State-owned China National Chemical Corp [CNNCC.UL], which plans to buy Swiss seeds and pesticide maker Syngenta (VX:SYNN), will promptly start preparations for what could be a lengthy U.S. national security review, as the House Agriculture Committee chairman said he would monitor the deal.

Representative Michael Conaway, a Texas Republican who chairs the Agriculture Committee, is aware of the deal and "will be closely monitoring this as it develops," a committee spokeswoman said in an emailed statement to Reuters.

The $43 billion deal, which was announced on Wednesday as a way for China to better feed its 1.4 billion people, would face scrutiny from a U.S. government panel that reviews foreign acquisitions to establish whether they will harm national security.

Last month, the Committee on Foreign Investment in the United States, or CFIUS, stunned markets by blocking the $3.3 billion sale of Dutch company Philips' (AS:PHG) lighting unit to a consortium of Asian buyers.

Syngenta, which generates nearly a quarter of its revenue from North America, is the biggest seller of pesticides in North America and also a key player in seeds. Its U.S. headquarters are in North Carolina. It has other facilities in the state, as well a presence in California, Delaware, Iowa and Minnesota, among others.

Davor Pisk, Syngenta's chief operating officer, said the company performs no classified work for the U.S. government and none of its U.S. facilities appear to be near sensitive U.S. government facilities.

Still, the company plans to file promptly to CFIUS, which comprises representatives from 16 U.S. agencies including Treasury, Homeland Security and Defense.

"As is best practice in foreign acquisitions involving U.S. businesses, the parties will make a voluntary filing with CFIUS, even though no obvious national security concerns were identified during due diligence," Pisk said in an emailed statement.

SENSITIVE STUFF

One person familiar with the deal added that if issues cropped up, the companies were prepared to take steps to address potential problems. In past cases, mitigation has required asset sales.

Philips was not allowed to disclose the nature of the concerns raised by CFIUS last month. But the involvement of Chinese firms in the consortium and the fact that the unit produced semiconductors - an industry the U.S. considers part of its critical infrastructure - may have played a role.

CFIUS's national security concerns tend to focus on military contracting, high-tech assets, communications networks, as well as facilities which may have no apparent security issues but are near sensitive U.S. military bases.

In 2012, CFIUS stopped a small Chinese company, Ralls Corp, from buying a wind farm in Oregon because the farm was near a training site used to test unmanned drones.

Michael Wessel, a member of the U.S.-China Economic and Security Review Commission which was created to monitor China for Congress, said he expected CFIUS would take a hard look at the ChemChina deal for Syngenta.

"This is a $43 billion firm, I do not believe we are talking about basic nitrogen-based fertilizers but some very high value products," he said. "This should be subject to strict scrutiny."

The vast majority of deals that CFIUS looks at are approved, while a few are changed to address national security concerns raised by the inter-agency commission.

© Reuters. Logo of Syngenta on it's headquarters in Basel

CFIUS looked at 480 transactions between 2009 and 2013 and investigated 193 of them. An unknown number were withdrawn by companies during the review process and scrapped and one was formally rejected, according to a CFIUS annual report to Congress issued in 2015.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.